Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Philippines FDA/Mecolzine

Approved

STANDARD

Mecolzine

Laboratorios Vitoria, S.A.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 75417d717be9e7a9
Company: Laboratorios Vitoria, S.A.
Type: Standard

Approval Details

Approval Id: 75417d717be9e7a9
Drug Approval Philippines Name: Mecolzine
Product Name: Mecolzine
Registration Number: DR-XY48315
Brand Name: Mecolzine
Generic Name: Mesalazine
Dosage Form: Rectal Suppository
Dosage Strength: 500 mg
Manufacturer: Laboratorios Vitoria, S.A.
Trader: FAES FARMA, S.A.
Importer: Buergli Pharma, Inc.
Distributor: Buergli Pharma, Inc.
Trader Detail Path: /organization/faes-farma-sa
Issuance Date: 26 August 2022
Expiry Date: 26 August 2027
Pharmacologic Category: Intestinal Antiinflammatory Agent
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

75417d717be9e7a9

Type

Standard

Back to Philippines FDA Approvals

Mecolzine - Philippines FDA Drug Approval Details